Posts Archive

ELOQUENT-3 trial NCT02654132: Phase 2: An Investigational Immuno-therapy Trial of Pomalidomide and Low-dose Dexamethasone With or Without...

AMG 176 NCT02675452: Phase 1 - AMG 176 First in Human Trial in RRMM / Relapsed or Refractory AML AMG 176 First in Human Trial in...

NCT02693535: Phase 2: TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a...

Myeloma Canada: Patient Handbook - Myeloma and the Kidney https://myeloma.ca/pixms/uploads/serve/ckeditor/mc_kidney_booklet_en_02_2017_we...

On November 21, 2016, the U.S. Food and Drug Administration approved daratumumab (DARZALEX, Janssen Biotech, Inc.) in combination with...

NCT02969837: Phase 2 - Study of Initial Treatment With Elotuzumab, Carfilzomib, Lenalidomide and Dexamethasone in Multiple Myeloma...

NCT02786511: Longterm Follow-up of Subjects Treated With bb2121 NCT02786511: Longterm Follow-up of Subjects Treated With bb2121 This is a...

A Phase I Study of Lintuzumab-Ac225 in Patients With Refractory Multiple Myeloma Establish the MTD of Lintuzumab-Ac225 as monotherapy...

The CASSIOPEIA trial IFM / HOVON IFM 2015-01 HOVON HO131 MM Newly Diagnosed Multiple Myeloma A Study to Evaluate Daratumumab in...

STORM Selinexor Treatment of Refractory Myeloma (STORM) This is a Phase 2b, single-arm, open-label, multicenter study of selinexor 80 mg...

Multiple Myeloma Research Consortium NCT02332850: Phase Ib Study of SAR650984 With Carfilzomib for Treatment of Relapsed Multiple Myeloma...

Cleveland Clinic Cancer Therapy: Oral Medication Basics: Information for Patients and Families (Targeted Therapy)

Cleveland Clinic: Cancer Therapy: Oral Medication Basics: Information for Patients and Families (Chemotherapy)

Myeloma UK - Myeloma Animations Proteasome inhibitors in myeloma Learn More: https://www.myeloma.org.uk/

NCT02538198: Phase 2 - Lenalidomide Maintenance in Plasma Cell Myeloma This is a Phase 2 study to assess the good and bad effects of...

Myeloma UK - Myeloma Animations Immunotherapy in myeloma Learn More: https://www.myeloma.org.uk/

GEM-CESAR trial PETHEMA/GEM Spanish Myeloma Group GEM (Grupo Español de Mieloma)/PETHEMA (Programa para el Estudio de la Terapéutica en...

11/30/2015: Bristol-Myers Squibb and AbbVie Receive FDA Approval of Empliciti™ (elotuzumab) for the Treatment of Patients with Multiple...

Study of elotuzumab in combination with pomalidomide and low dose dexamethasone (EPd Cohort) and elotuzumab in combination with nivolumab...

STOMP Selinexor and Backbone Treatments of Multiple Myeloma Patients (STOMP) This study will independently assess the efficacy and safety...

FDA Approved for RRMM: Panobinostat (Farydak) Capsules + Bortezomib(Velcade) and Dexamethasone Relapsed & Refractory Multiple Myeloma...

Myeloma UK - Myeloma Animations Genetic causes of myeloma Learn More: https://www.myeloma.org.uk/

Nature Videos: Tumour immunology and immunotherapy https://www.nature.com/